NFCR-Backed Technology Receives FDA’s Assent for Lymphoma Clinical Trials
A drug and drug delivery candidate technology, research into which has been funded by the National Foundation for Cancer Research (NFCR), has recently been approved by the U.S. Food and Drug Administration (FDA) for the initiation of human clinical trials.…